![](https://endpts.com/wp-content/uploads/2022/03/Greg-Verdine-LifeMine-via-Harvard-tile-scaled.jpg)
Greg Verdine, LifeMine CEO (via Harvard)
Greg Verdine will have many new C-suite friends at fungus biotech LifeMine after GSK-fueled $175M round
A year after securing funds from Rick Klausner and adding Nobel laureate William Kaelin to the board, fungus-focused LifeMine Therapeutics is ready to reveal …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.